Alvotech is trading at ISK 708.00, down 5.09%, amid biotech weakness, the clearest supporting context for the October 9, 2026 decline, though no direct cause is established.
- No clear company-specific news explaining the decline was identified. Reports on the previously announced LOTTE Biologics manufacturing partnership, which expands U.S. production capacity, do not link it to the drop.
- XBI was down 2.04%; no trading-volume information was provided.